Search Results 481-490 of 16583 for Acrivastine

  1. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...

  2. Radiology - Doctors - Mayo Clinic

    Learn about the radiology expertise and services offered at Mayo Clinic to solve the most serious and complex medical questions for people who turn to the ...

  3. Efavirenz (oral route) - Side effects & dosage - Mayo Clinic

    This medicine will not cure HIV infection or AIDS. It works by lowering the amount of HIV in the blood and helps the immune system. This may help delay some of ...

  4. Cardiovascular Medicine - Clinical trials

    Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

  5. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

    FASN inhibitor TVB-2640 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  6. Treatment

    Ependymoma treatment options include: Surgery. Brain surgeons, called neurosurgeons, work to remove as much of the ependymoma as possible.

  7. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effect of rilonacept added to standard therapy on improvement in myocardial inflammation in ...

  8. Teclistamab-cqyv (subcutaneous route) - Side effects & uses - Mayo Clinic

    Teclistamab-cqyv injection is used to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma in ...

  9. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis · Overview · Participation ...

  10. Neurology - Clinical trials - Mayo Clinic

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...